News
IDIBELL project, funded by EMBO
Dr. Antonio Gentilella has get an EMBO Long-Term Fellowship The project, leaded by Dr. Antonio Gentilella and funded by an EMBO Long-Term Fellowship, is focussed on understanding the mechanisms by which the tumor suppressor p53, also known as the guardian of genome, is activated in response to ribosomal impairment, a cause of two rare anemias, […]
Identified an anti-oncogene into an oncogene
A study led by Manel Esteller has discovered the existence of an antitumor molecule that has been originated within an oncogene. A common point in all human tumors is that they produce an activation of oncogenes, genes that cause cancer and they also cause a loss of function of the protective genes, called anti-oncogenes or […]
World No Snuff
25% of IDIBELL staff is smoker May 31 is the World without Snuff. The Smoke-Free IDIBELL program is aimed at workers ready to quit smoking. It is a free personalized program offered by the Tobacco Control Unit of the ICO. To qualify for the Smoke-Free program IDIBELL, the smoker must be motivated to quit. According […]
First epigenome in Europe completed
A study led by Manel Esteller compares the epigenetic marks of a healthy person with a patient with a genetic disease Methylation Article’s reference:
Identify genetic markers to predict male fertility
The diagnosis of male fertility is usually performed through the observation of the sperm in the microscope. However, a normal quality semen does not guarantee an adequate fertility. In fact, there is a considerable proportion of cases of unexplained infertility and data suggest that abnormal sperm function may have a genetic or molecular origin. A […]
Discovered a new checkpoint of cell cycle control through joint action of two proteins
Alterations in the formation of ribosomes (the elements of the cell where proteins are made) cause the induction of p53 protein and cell cycle disruption. This process is crucial to understand fundamental biological processes and the emergence of various diseases. Now, scientists at the Bellvitge Biomedical Research Institute (IDIBELL) have found that this response is […]
New key mechanism in cell division discovered
Researchers from the Bellvitge Biomedical Research Institute (IDIBELL) have identified the mechanism by which protein Zds1 regulates a key function in mitosis, the process that occurs immediately before cell division. The result has been achieved in the online edition of the Journal of Cell Science and opens the door to developing targeted and direct therapies […]
Top researcher George Thomas joins IDIBELL
The Bellvitge Biomedical Research Institute (IDIBELL) has recruited the researcher George Thomas, one of the leading international scientists in cancer and metabolic diseases. Dr. Thomas’ research focuses on the metabolic processes that are behind human diseases, which has led him to similar findings in apparently different diseases such as cancer, diabetes and obesity. George Thomas […]
The Minister of Health inaugurates new lab on Metabolism and Cancer
The Catalan Minister of Health, Boi Ruiz, has inaugurated the new Laboratory of Metabolism and Cancer of IDIBELL. The opening ceremony, held on May 11th, was attended by the mayor of L’Hospitalet de Llobregat, Nuria Marin, and representatives of IDIBELL partner institutions (Bellvitge University Hospital, Catalan Institute of Oncology and the University of Barcelona) as […]